Skip to content

Clinical trials

Phase 3 Anemia, Iron-Deficiency trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anemia, Iron-Deficiency Phase: Phase 3 Country / region: United States Clear all

33 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20093
20102
20113
20141
20151
20165
20174
20181
20193
20201
20214
20222
20231
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed23
Recruiting5
Terminated3
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AMAG Pharmaceuticals, Inc.8
Pharmacosmos A/S7
American Regent, Inc.5
Shield Therapeutics3
Baylor College of Medicine2
AFT Pharmaceuticals, Ltd.1
Ann & Robert H Lurie Children's Hospital of Chicago1
Auerbach Hematology Oncology Associates P C1
Denver Nephrologists, P.C.1
Stanford University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anemia, Iron-Deficiency33
Renal Insufficiency, Chronic8
Iron Deficiencies5
Anemia3
Hyperphosphatemia2
Hypophosphatemia2
Renal Insufficiency2
Crohn Disease1
Deficiency Diseases1
Disease Progression1

Trials

Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.